RAPP
Rapport Therapeutics, Inc.
27.02
+1.06 (+4.08%)
52w low 22.06
52.93 high
16.1% of range
RAPP · 6M
—
O--
H--
L--
C--
Chg--
Gap--
Vol--
×avg--
σ--
SMA20--
SMA50--
SMA200--
RSI--
SPY--
DD--
Bench--
Sig--
Hist--
pinned · Esc to release
hover · click to pin · ← → step · drag to zoom · shift-drag to measure
SMA 20SMA 50
—Context
- Move across the chart.
Events in view
| Date | Kind | Event | Source |
|---|---|---|---|
| 2026-11-04 | filing | 8-K: results of operations (earnings) | SEC EDGAR |
| 2026-11-04 | filing | 10-Q (quarterly report) | SEC EDGAR |
| 2026-10-30 | filing | 424B5 (prospectus supplement (offering)) | SEC EDGAR |
| 2026-10-30 | filing | 424B5 (prospectus supplement (offering)) | SEC EDGAR |
| 2026-10-30 | filing | 8-K: material agreement; results of operations (earnings); new debt obligation; unregistered sale of equity (dilution) | SEC EDGAR |
| 2026-10-27 | filing | 424B5 (prospectus supplement (offering)) | SEC EDGAR |
| 2026-10-27 | filing | 424B5 (prospectus supplement (offering)) | SEC EDGAR |
| 2026-10-20 | filing | 8-K: Reg FD disclosure; other events | SEC EDGAR |
| 2026-08-05 | filing | 8-K: results of operations (earnings) | SEC EDGAR |
| 2026-08-05 | filing | 10-Q (quarterly report) | SEC EDGAR |
| 2026-06-10 | filing | 8-K: shareholder vote | SEC EDGAR |
| 2026-05-07 | filing | 8-K: results of operations (earnings) | SEC EDGAR |
| 2026-05-07 | filing | 10-Q (quarterly report) | SEC EDGAR |
Performance
1D
+4.08%
5D
+4.20%
1M
-10.38%
3M
-43.39%
6M
-29.04%
YTD
-10.94%
1Y
+5.96%
2Y
+0.45%
3Y
--
5Y
--
MAX
+16.17%
Period
-27.09%
High
52.93
Low
22.06
Ann Vol
49.82%
Sharpe
-0.48
Max DD
-57.14%
ATR (14)
2.17